| Breast Cancer |
1 |
1 |
| Cancer |
0 |
0.94 |
| Lung Cancer |
0 |
0.83 |
| Otolaryngology |
0 |
0.82 |
| Biologic Therapy |
0 |
0.75 |
| Renal Cell Carcinoma |
0 |
0.74 |
| Advanced and Metastatic Breast Cancer |
0 |
0.69 |
| Endometrial Cancer |
0 |
0.69 |
| Kidney Cancer |
0 |
0.69 |
| Metastasis |
0 |
0.69 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.69 |
| Ovarian Cancer |
0 |
0.69 |
| Pancreatic Cancer |
0 |
0.69 |
| Cervical Cancer |
0 |
0.68 |
| Antineoplastic Drug |
0 |
0.67 |
| Esophageal Cancer |
0 |
0.67 |
| Triple Negative Breast Cancer |
0 |
0.67 |
| Non-Small Cell Lung Cancer |
0 |
0.65 |
| Toxicology |
0 |
0.65 |
| Breast |
0 |
0.25 |
| Lung |
0 |
0.15 |
| Chemotherapy |
0 |
0.12 |
| Generics |
0 |
0.11 |
| Antidepressant drug |
0 |
0.1 |
| Depression |
0 |
0.1 |
| Sarcoma |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |
| Drug Interaction |
0 |
0.07 |
| Humanized Monoclonal Antibody |
0 |
0.07 |
| Military and Health |
0 |
0.07 |